Dark

CPRX
Catalyst Pharmaceutical Inc.
stock NASDAQ

At Close

May 16, 2025 3:59:30 PM EDT

24.37USD+2.481%(+0.59)988,214

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 16, 2025 9:25:30 AM EDT

23.37USD-1.724%(-0.41)5,288

After-hours

May 16, 2025 4:40:30 PM EDT

24.37USD0.000%(0.00)2,940

OverviewOptionsHistoricalExchangesShortsNews

Jan 28, 2022

01:50PM EST Catalyst Pharmaceuticals Announces Issuance Of Mandate By U.S. Court of Appeals For 11th Circuit Directing The District Court Judge In Co's Lawsuit Against The FDA To Grant Summary Judgement In Favor of Catalyst Benzinga

01:47PM EST Catalyst Pharmaceuticals Announces Issuance of Mandate by the U.S. GlobeNewswire Inc

Jan 10, 2022

08:06AM EST Catalyst Pharmaceuticals Announces 11th Circuit Court Of Appeals Denial Of Jacobus Pharmaceutical Company Inc.'s Petition For Rehearing Benzinga

08:03AM EST Catalyst Pharmaceuticals Announces 11th Circuit Court of Appeals GlobeNewswire Inc

Jan 4, 2022

07:30AM EST Catalyst Pharmaceuticals to Participate in January 2022 Virtual GlobeNewswire Inc

Dec 6, 2021

07:14AM EST Catalyst Pharmaceuticals Announces DyDo Pharma Initiation of a Phase 3 Study for FIRDAPSE Benzinga

07:14AM EST Catalyst Pharmaceuticals Announces DyDo Pharma Initiation Of A Phase 3 Study For FIRDAPSE In Japan Benzinga

07:00AM EST Catalyst Pharmaceuticals Announces DyDo Pharma Initiation of a GlobeNewswire Inc

Nov 19, 2021

04:47PM EST 'Catalyst Pharma: A Rare Orphan Drug Opportunity With Low Risk' -Seeking Alpha Blog Post From Contributor Benzinga

Nov 9, 2021

06:28PM EST Catalyst Pharmaceuticals Q3 Adj. EPS $0.14 Beats $0.10 Estimate, Sales $35.90M Beat $34.59M Estimate Benzinga

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Oct 25, 2021

08:03AM EDT Catalyst Pharmaceuticals, Inc.(Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today announced that it will release its third quarter 2021 financial results after market close on Tuesday, November 9, 2021. GlobeNewswire Inc

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Sep 30, 2021

12:09PM EDT Catalyst Pharmaceuticals Receives Decision from Appeals Court That Supports Orphan Drug Exclusivity for Firdapse for LEMS, Confirming Earlier Report Benzinga

12:08PM EDT Catalyst Pharmaceuticals Receives Positive Decision from Appeals GlobeNewswire Inc

Sep 27, 2021

10:20AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Sep 17, 2021

08:08AM EDT Catalyst Pharmaceuticals To Participate At Oppenheimer Fall Healthcare Life Sciences & MedTech Summit On Sept. 21 Benzinga

08:03AM EDT Catalyst Pharmaceuticals to Participate at the Oppenheimer Fall GlobeNewswire Inc

Sep 15, 2021

12:04PM EDT Catalyst Pharmaceuticals's Return On Capital Employed Overview Benzinga

Sep 10, 2021

08:03AM EDT Catalyst Pharmaceuticals to Participate in Two Upcoming Investor GlobeNewswire Inc

Aug 16, 2021

08:03AM EDT Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, GlobeNewswire Inc

Aug 9, 2021

05:25PM EDT Catalyst Pharmaceuticals Q2 Adj. EPS $0.16 Beats $0.09 Estimate, Sales $36.40M Beat $31.51M Estimate Benzinga

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

04:11AM EDT Earnings Scheduled For August 9, 2021 Benzinga

Aug 8, 2021

10:11AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Jul 26, 2021

08:03AM EDT Catalyst Pharmaceuticals to Hold Second Quarter 2021 Financial GlobeNewswire Inc

Jul 19, 2021

08:08AM EDT Catalyst Pharmaceuticals Announces Issuance Of US Patent 11,060,128 A Method Of Use Patent With Claims Covering Firdapse Benzinga

08:03AM EDT -- New patent bolsters intellectual property protection for Firdapse -- First in a family of four pending patents for Firdapse to issue GlobeNewswire Inc

Jul 12, 2021

10:02AM EDT 5 Value Stocks In The Healthcare Sector Benzinga

Jul 6, 2021

08:03AM EDT Catalyst Pharmaceuticals Expands Leadership Team with Appointment GlobeNewswire Inc

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

08:16AM EDT Catalyst Pharma Appoints Molly Harper To Board RTTNews

08:03AM EDT Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced the appointment of Molly Harper to the Companys Board of Directors. GlobeNewswire Inc

Jun 28, 2021

04:30PM EDT Catalyst Pharmaceuticals Comments on Recent Decision by Health GlobeNewswire Inc

08:19AM EDT Catalyst Pharma Announces License And Supply Agreement With DyDo Pharma For Commercialization Of Firdapse In Japan RTTNews

08:11AM EDT Catalyst Pharmaceuticals Announces Exclusive License And Supply Agreement With DyDo Pharma For Development And Commercialization Of Firdapse In Japan; Financial Details Not Disclosed Benzinga

08:03AM EDT Catalyst Pharmaceuticals Announces Exclusive License and Supply GlobeNewswire Inc

Jun 25, 2021

10:35AM EDT Catalyst Pharmaceuticals Insights: Return On Capital Employed Benzinga

07:32AM EDT The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs Benzinga

Jun 11, 2021

08:05AM EDT The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts Benzinga

Jun 9, 2021

10:42AM EDT Catalyst Pharmaceuticals Insights: Return On Capital Employed Benzinga

Jun 3, 2021

03:10PM EDT Catalyst Pharmaceuticals, Inc.'s and KYE Pharmaceuticals' Lawsuit in Canadian PR Newswire

01:22PM EDT Catalyst Pharmaceuticals Says Co's, KYE Pharmaceuticals' Lawsuit In Canadian Federal Court 'Quashes The Notice of Compliance (NOC) For Ruzurgi' Benzinga

01:20PM EDT - Without an NOC, Ruzurgi is without a Marketing Authorization in Canada GlobeNewswire Inc

May 21, 2021

07:26AM EDT The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying Benzinga

May 19, 2021

08:03AM EDT Catalyst Pharmaceuticals to Participate in Two Upcoming Investor GlobeNewswire Inc

07:30AM EDT The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics Benzinga

May 18, 2021

07:44AM EDT The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO Benzinga

May 10, 2021

05:31PM EDT Catalyst Pharmaceuticals Q1 Net Income $11.6M, Sales $30.20M Miss $32.10M Estimate Benzinga

05:30PM EDT Catalyst Pharmaceuticals Announces First Quarter 2021 Financial GlobeNewswire Inc

04:09AM EDT Earnings Scheduled For May 10, 2021 Benzinga

May 7, 2021

10:06AM EDT Earnings Outlook for Catalyst Pharmaceuticals Benzinga

May 3, 2021

08:05AM EDT Catalyst Pharmaceuticals to Hold First Quarter 2021 Financial GlobeNewswire Inc

Mar 22, 2021

09:49AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

08:07AM EDT Catalyst Pharmaceuticals Announces $40M Buyback Benzinga

08:03AM EDT Catalyst Pharmaceuticals Announces $40 Million Share Repurchase GlobeNewswire Inc

Mar 18, 2021

10:31AM EDT Roth Capital Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $7 Benzinga

Mar 15, 2021

05:27PM EDT Catalyst Pharmaceuticals Q4 EPS $0.11 Beats $0.09 Estimate, Sales $31.00M Beat $30.35M Estimate Benzinga

05:26PM EDT - Firdapse Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million GlobeNewswire Inc

04:53AM EDT Earnings Scheduled For March 15, 2021 Benzinga

Mar 14, 2021

08:14AM EDT Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations Benzinga

Mar 4, 2021

11:00AM EST Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 GlobeNewswire Inc

Feb 22, 2021

08:03AM EST -- Catalyst Supporting Facebook Live Panel on Living with a Rare Disease Hosted by The Mighty -- Catalyst Kicks off Rare Reason Campaign GlobeNewswire Inc

Jan 28, 2021

10:44AM EST Looking Into Catalyst Pharmaceuticals's Return On Capital Employed Benzinga

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 6, 2021

08:09AM EST Catalyst Pharmaceuticals Sees Firdapse 2020 Net Revenues ~$118M, Up 16% YoY Benzinga

08:07AM EST -- Company to Expand R&D Focus for Pipeline Growth to include Earlier Stage Programs and Validated Technology Platforms -- Firdapse 2020 Net Revenues Estimate of approximately $118 Million; about 16% Increase From 2019 -- Ended 2020 with Estimated $140 Million in Cash and Investments -- Company Highlights Current Product Development Programs GlobeNewswire Inc

Dec 26, 2020

09:16AM EST The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks Benzinga

Dec 14, 2020

09:59AM EST A Look Into Healthcare Sector Value Stocks Benzinga

Nov 9, 2020

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 2, 2020

10:11AM EST 5 Value Stocks In The Healthcare Sector Benzinga

08:03AM EST Catalyst Pharmaceuticals to Hold Third Quarter 2020 Financial GlobeNewswire Inc

Oct 28, 2020

11:00AM EDT Looking Into Catalyst Pharmaceuticals's Return On Capital Employed Benzinga

Oct 19, 2020

06:05AM EDT Catalyst Pharmaceuticals Announces Filing of Patent Infringement Actions Against Jacobus Pharmaceuticals and PantherRx Benzinga

06:03AM EDT Catalyst Pharmaceuticals Announces Filing of Patent Infringement GlobeNewswire Inc

Oct 6, 2020

11:21AM EDT Catalyst Pharma Reports US Patent And Trademark Office Issued New US Patent To Co. For Firdapse, US Patent '893, 'Methods of Administering 3,4-Diaminopyridine,' Expiring April 7, 2034 Benzinga

11:15AM EDT Catalyst Pharmaceuticals Announces Issuance of U.S. Patent for GlobeNewswire Inc

10:01AM EDT Return On Capital Employed Overview: Catalyst Pharmaceuticals Benzinga

Sep 29, 2020

04:43PM EDT UPDATE: Catalyst Pharma Says District Judge Rejected Co.'s Argument The Approved Labeling For Ruzurgi Is False, Misleading Benzinga

04:41PM EDT Catalyst Pharma Reports District Judge Found Co.'s Interpretation Of Orphan Drug Act 'not necessarily wrong, but it is not the only reasonable way to interpret the plain language of the statute' Benzinga

04:40PM EDT Catalyst Pharmaceuticals Announces Ruling on Lawsuit against the GlobeNewswire Inc

Aug 26, 2020

09:42AM EDT KYE Pharmaceuticals, Catalyst Pharmaceuticals Challenge Health Canada's Decision To Overlook Firdapse Data Exclusivity Benzinga

09:40AM EDT KYE Pharmaceuticals and Catalyst Pharmaceuticals Challenge Health GlobeNewswire Inc

Aug 18, 2020

08:21AM EDT Catalyst Pharmaceuticals And KYE Pharmaceuticals Announce Agreement To Make Firdapse Available To LEMS Patients In Canada Benzinga

08:03AM EDT Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce GlobeNewswire Inc

Aug 14, 2020

10:30AM EDT ROCE Insights For Catalyst Pharmaceuticals Benzinga

Aug 12, 2020

07:18AM EDT Truist Securities Maintains Buy on Catalyst Pharmaceuticals, Lowers Price Target to $8 Benzinga

Aug 11, 2020

06:18AM EDT Catalyst Pharma: USPTO Issues Notice Of Allowance Of Patent Application For Methods Of Administering 3,4-Diaminopyridine RTTNews

06:14AM EDT Catalyst Pharmaceuticals Announces Notice Of Allowance Of US Patent Application For 'Methods of Administering 3,4-Diaminopyridine' Benzinga

06:00AM EDT Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. GlobeNewswire Inc

Aug 10, 2020

04:55PM EDT Catalyst Pharmaceuticals Q2 EPS $0.09 Beats $0.08 Estimate, Sales $29.60M Beat $29.48M Estimate Benzinga

04:15PM EDT Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 10, 2020 Benzinga

Aug 7, 2020

11:11AM EDT Earnings Preview: Catalyst Pharmaceuticals Benzinga

Aug 6, 2020

08:09AM EDT Catalyst Pharma Reports Firdapse For Patients With Lambert-Eaton Myasthenic Syndrome Receives Marketing Approval In Canada Benzinga

Aug 4, 2020

01:30PM EDT Here's How Much Investing $1,000 In Catalyst Pharmaceuticals In 2010 Would Be Worth Today Benzinga

Aug 3, 2020

04:15PM EDT Catalyst Pharmaceuticals Announces Change to a Virtual Meeting GlobeNewswire Inc

08:03AM EDT Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial GlobeNewswire Inc

Jul 31, 2020

11:14AM EDT UPDATE: Magistrate Judge Recommends To District Judge Handling Case That She Grat FDA's, Jacobus' Motions FOr Summary Judgement And Deny Co.s Motion For Summary Judgement Benzinga

11:12AM EDT Catalyst Pharmaceuticals Comments On Magistrate Judge's Report, Recommendation In Its Lawsuit Against FDA Benzinga

11:10AM EDT Catalyst Pharmaceuticals Comments on Magistrate Judge's Report and GlobeNewswire Inc